Pharmaceutical Technology Europe
The way in which a suspension nasal spray product interacts with the body depends not only on the droplet size of the delivered droplet, but also on the particle size of the suspended API.
Julie Suman
Advertisement
Julie Suman is President at NextBreath LLC, USA.
Articles by Julie Suman
Pharmaceutical Technology Europe
One particularly crucial parameter for nasal sprays is the size of the droplets produced during actuation, which can potentially impact bioavailability.
Advertisement
Latest Updated Articles
Understanding The Requirements For Effective Nasal Drug DeliverySeptember 1st 2010
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA Duloxetine Recall Highlights Generic Manufacturing Quality Gaps
2
Germany Pharma Tariff Threat: What Manufacturers Need to Know
3
Why Pharma Dealmaking Slowed in Q1 2026 and What Is Coming Next
4
PharmTech Weekly Roundup—June 19, 2026
5